BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beaupere C, Liboz A, Fève B, Blondeau B, Guillemain G. Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance. Int J Mol Sci 2021;22:E623. [PMID: 33435513 DOI: 10.3390/ijms22020623] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Feng Y, Li Y, Jiang W, Hu Y, Jia Y, Zhao R. GR-mediated transcriptional regulation of m6A metabolic genes contributes to diet-induced fatty liver in hens. J Anim Sci Biotechnol 2021;12:117. [PMID: 34872591 DOI: 10.1186/s40104-021-00642-7] [Reference Citation Analysis]
2 Shi XT, Zhu HL, Xu XF, Xiong YW, Dai LM, Zhou GX, Liu WB, Zhang YF, Xu DX, Wang H. Gestational cadmium exposure impairs placental angiogenesis via activating GC/GR signaling. Ecotoxicol Environ Saf 2021;224:112632. [PMID: 34411824 DOI: 10.1016/j.ecoenv.2021.112632] [Reference Citation Analysis]
3 Kokkinopoulou I, Diakoumi A, Moutsatsou P. Glucocorticoid Receptor Signaling in Diabetes. Int J Mol Sci 2021;22:11173. [PMID: 34681832 DOI: 10.3390/ijms222011173] [Reference Citation Analysis]
4 Motavalli R, Majidi T, Pourlak T, Abediazar S, Shoja MM, Zununi Vahed S, Etemadi J. The clinical significance of the glucocorticoid receptors: Genetics and epigenetics. J Steroid Biochem Mol Biol 2021;213:105952. [PMID: 34274458 DOI: 10.1016/j.jsbmb.2021.105952] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Merabet N, Lucassen PJ, Crielaard L, Stronks K, Quax R, Sloot PMA, la Fleur SE, Nicolaou M. How exposure to chronic stress contributes to the development of type 2 diabetes: a complexity science approach. Front Neuroendocrinol 2021;:100972. [PMID: 34929260 DOI: 10.1016/j.yfrne.2021.100972] [Reference Citation Analysis]
6 Bel JS, Tai TC, Khaper N, Lees SJ. Chronic glucocorticoid exposure causes brown adipose tissue whitening, alters whole-body glucose metabolism and increases tissue uncoupling protein-1. Physiol Rep 2022;10:e15292. [PMID: 35510321 DOI: 10.14814/phy2.15292] [Reference Citation Analysis]
7 Di Vincenzo M, Martino M, Lariccia V, Giancola G, Licini C, Di Benedetto G, Arnaldi G, Orciani M. Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing’s Syndrome. Front Endocrinol 2022;13:816229. [DOI: 10.3389/fendo.2022.816229] [Reference Citation Analysis]
8 Sumińska M, Podgórski R, Fichna P, Fichna M. Steroid Metabolism in Children and Adolescents With Obesity and Insulin Resistance: Altered SRD5A and 20α/20βHSD Activity. Front Endocrinol (Lausanne) 2021;12:759971. [PMID: 34764940 DOI: 10.3389/fendo.2021.759971] [Reference Citation Analysis]
9 Batra A, Latsko M, Portella AK, Silveira PP. Early adversity and insulin: neuroendocrine programming beyond glucocorticoids. Trends Endocrinol Metab 2021;32:1031-43. [PMID: 34635400 DOI: 10.1016/j.tem.2021.09.003] [Reference Citation Analysis]
10 Infante M, Padilla N, Alejandro R, Caprio M, Della-morte D, Fabbri A, Ricordi C. Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents. Medicina 2022;58:571. [DOI: 10.3390/medicina58050571] [Reference Citation Analysis]